Company profile: Blockade Medical
1.1 - Company Overview
Company description
- Provider of catheter-based therapeutic devices for the treatment of cerebral aneurysms. Founded in 2011, Blockade Medical is a privately held company with a management team totaling 65+ years in the neurovascular field, committed to bringing products to market that are current standards of care.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Blockade Medical
Magstim
HQ: United Kingdom
Website
- Description: Provider of Transcranial Magnetic Stimulation (TMS) stimulators and packages for Magstim TMS therapy and neuromodulation research. Offers Magstim TMS Therapy for depression, StimGuide for precise TMS delivery, and Neurosign intraoperative nerve monitoring solutions. Provides installation, certification training, and dedicated engineering service and support. Magstim stimulators are used in the majority of published TMS research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magstim company profile →
Pulsar Vascular
HQ: United States
Website
- Description: Provider of an endovascular platform addressing bifurcation aneurysms, offering the PulseRider Neck Reconstruction Device, a neck-bridge solution designed to span the aneurysm neck and support and stabilize an embolic coil mass.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pulsar Vascular company profile →
Akome Biotech
HQ: Canada
Website
- Description: Provider of psychedelic-based pharmaceuticals for rare diseases and mental disorders, targeting treatments for cluster headaches, Alzheimer’s disease, and depression, serving patients suffering from stroke and neurological illnesses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akome Biotech company profile →
Cybin
HQ: Canada
Website
- Description: Provider of clinical-stage psychedelic-based therapeutics for mental health conditions, including CYB003, a deuterated psilocybin analog for Major Depressive Disorder with positive Phase 2 data, and CYB004, a deuterated DMT molecule aimed at treating Generalized Anxiety Disorder, with a US Phase 2 study expected to begin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cybin company profile →
Neural Therapeutics
HQ: Canada
Website
- Description: Provider of ethnobotanical drug discovery, psychedelic-based therapeutics for mental health, and dietary supplements. Focuses on San Pedro cactus for mescaline-derived compounds, conducts pharma and nutraceutical R&D leveraging indigenous knowledge, develops IP with partners like Validity Labs, and establishes sustainable, legally compliant sourcing and cultivation in Peru.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neural Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Blockade Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Blockade Medical
2.2 - Growth funds investing in similar companies to Blockade Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Blockade Medical
4.2 - Public trading comparable groups for Blockade Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →